IRIS
BRUZZONE, BIANCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.003
Totale 4.003
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 4.003
Totale 4.003
Salva come PNG Salva come JPEG
Città #
Genova 2.482
Genoa 807
Rapallo 683
Bordighera 31
Totale 4.003
Salva come PNG Salva come JPEG
Nome #
Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maraviroc 166
Fifteen years of epidemiologic, virologic and syndromic influenza surveillance: A focus on type B virus and the effects of vaccine mismatch in Liguria region, Italy 136
Analysis of a 3-months measles outbreak in western Liguria, Italy: Are hospital safe and healthcare workers reliable? 116
Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy 115
Correct Identification of Dual HCV Infections in HIV/HCV CoInfected Patients 112
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 111
Simplification to monotherapy with lopinavir/ritonavir in adolescents with vertically acquired HIV-1 infection. 106
Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab 106
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 104
Resolution of porphyria cutanea tarda in HIV and mixed HCV coinfection after direct-acting antiviral (DAA) therapy 100
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 99
Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study 98
Overview of hepatitis B virus mutations and their implications in the management of infection 95
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 93
From a medical mistake to a clinical warning: The case of HBV mutant virus reactivation in haematological patients 92
How relevant is the HIV low level viremia and how is its management changing in the era of modern ART? A large cohort analysis 90
Unexpected high rate of wild-type HIV-1 genotype among inmates failing antiretroviral therapy 88
Vaginal HIV-1 shedding among HIV-1 infected women in the current era of combined antiretroviral therapy: a cross sectional study 85
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 81
Pregnancy outcomes following exposure to efavirenz-based antiretroviral therapy in the Republic of Congo 81
Bloodstream infections in critically ill patients with COVID-19 80
Short Communication: Tenofovir Disoproxil Fumarate/Emtricitabine Fits for All as Appropriate HIV-1 Pre-Exposure Prophylaxis? 79
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 79
Xpert HIV-1 viral load assay and versant HIV-1 RNA 1.5 assay: A performance comparison 73
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 71
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group 66
Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients 66
Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA) 66
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 65
Emerging mutations at virological failure of HAART combinations containing tenofovir and lamivudine or emtricitabine 65
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 62
Ligurian Vaccination in HIV Program (LIV in HIV): the experience of Genoa metropolitan area 59
Impact of the M184V resistance mutation on virological efficacy and durability of lamivudine-based dual antiretroviral regimens as maintenance therapy in individuals with suppressed HIV-1 RNA: A cohort study 58
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 58
Prevalence and determinants of resistance mutations in HIV-1-infected patients exposed to integrase inhibitors in a large Italian cohort 57
Update on emergence of HIV-1 resistance to antiretroviral drug classes in an Italian national database: 2007-2009 56
CD8+CD28-CD127loCD39+Treg Expansion: a New Pathogenic Mechanism for HIV Infection? 55
Prevalence of mutations and determinants of genotypic resistance to etravirine (TMC125) in a large Italian resistance database (ARCA) 55
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 47
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG 46
Immunological profile of an infant treated with integrase inhibitor from the neonatal period 46
Characterization of T lymphocytes in severe COVID-19 patients 44
Duration of isolation and precautions in immunocompromised patients with COVID-19 42
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings 41
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection 39
Comparative diagnostic performance of a novel reverse transcription loop-mediated isothermal amplification (RT-LAMP) kit for the rapid detection of SARS-CoV-2 37
Determinants of SARS-CoV-2 infection in Italian healthcare workers: a multicenter study 36
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen 35
Effect of the 2020/21 season influenza vaccine on SARS-CoV-2 infection in a cohort of Italian healthcare workers 33
Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers 33
Hepatitis E Virus Infection in an Italian Cohort of Hematopoietic Stem Cell Transplantation Recipients: Seroprevalence and Infection 30
Acceptance of COVID-19 and Influenza Vaccine Co-Administration: Insights from a Representative Italian Survey 29
Comparative diagnostic performance of rapid antigen detection tests for COVID-19 in a hospital setting 28
Changes in attitudes and beliefs concerning vaccination and influenza vaccines between the first and second covid-19 pandemic waves: A longitudinal study 28
Adverse Reactions after the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine among Medical School Residents in a Regional Reference University Hospital in Italy 27
Marked decrease in acquired resistance to antiretrovirals in latest years in Italy 27
Reactogenicity of bnt162b2 mrna covid-19 vaccine in a young working age population: A survey among medical school residents, within a mass vaccination campaign, in a regional reference teaching hospital in italy 27
Comparative Diagnostic Accuracy of the {STANDARD} M10 Assay for the Molecular Diagnosis of {SARS}-{CoV}-2 in the Point-of-Care and Critical Care Settings 23
Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients 22
Investigating SARS-CoV-2 transmission among co-workers in a University of Northern Italy during COVID-19 pandemic: an observational study 22
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 21
No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020 21
Effect of SARS-CoV-2 vaccination in a vulnerable COVID-19 cohort: a real-life experience in an Italian Hospital 20
Lamivudine resistance mutations in European patients with hepatitis B and patients co-infected with HIV and hepatitis B 19
Comparative Analysis of Five Multiplex RT-PCR Assays in the Screening of SARS-CoV-2 Variants 19
Darunavir-based dual therapy in HIV experienced patients 19
Evaluation of extraction-free RT-qPCR methods for SARS-CoV-2 diagnostics 15
Outbreak of sars-cov-2 lineage 20i/501y.V1 in a nursing home underlines the crucial role of vaccination in both residents and staff 13
Monkeypox outbreak in Genoa, Italy: Clinical, laboratory, histopathologic features, management, and outcome of the infected patients 12
Nasal monkeypox virus infection successfully treated with cidofovir in a patient newly diagnosed with HIV 12
On-field evaluation of a ultra-rapid fluorescence immunoassay as a frontline test for SARS-CoV-2 diagnostic 12
Efficacy of the Sentinox Spray in Reducing Viral Load in Mild COVID-19 and Its Virucidal Activity against Other Respiratory Viruses: Results of a Randomized Controlled Trial and an In Vitro Study 10
How Long Can a Dead Body Remain Infectious?: Postmortem Nasopharyngeal Swabs and SARS-CoV-2 Culture in a Corpse Over an 87-Day Period 3
Herpes Simplex Virus 1 (HSV-1) Reactivation in Critically Ill COVID-19 Patients: A Brief Narrative Review 1
Totale 4.183
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.335
article - articoli 17.127
book - libri 0
conference - conferenze 208
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.670
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.011 60 23 21 63 72 94 171 104 118 163 88 34
2020/2021560 20 43 47 48 70 75 37 43 41 67 30 39
2021/2022615 40 16 27 76 20 33 37 126 64 59 26 91
2022/2023853 75 87 2 73 95 130 9 43 133 51 142 13
2023/2024695 30 77 12 91 69 124 41 49 29 28 48 97
2024/202532 32 0 0 0 0 0 0 0 0 0 0 0
Totale 4.183